These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26416059)

  • 1. Association of p16 gene methylation with prostate cancer risk: a meta-analysis.
    Feng W; Han Z; Zhu R; Liu P; Liu S
    J BUON; 2015; 20(4):1074-80. PubMed ID: 26416059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis.
    Shi DT; Han M; Gao N; Tian W; Chen W
    Tumour Biol; 2014 Feb; 35(2):943-8. PubMed ID: 23982879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Tissue Inhibitor of Metalloproteinase-3 Gene Methylation and Gastric Cancer Risk: A Meta-Analysis.
    Cao J; Li Z; Yang L; Liu C; Luan X
    Genet Test Mol Biomarkers; 2016 Aug; 20(8):427-31. PubMed ID: 27314831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between p16 Promoter Methylation and Thyroid Cancer Risk: A Meta-analysis.
    Wu W; Yang SF; Liu FF; Zhang JH
    Asian Pac J Cancer Prev; 2015; 16(16):7111-5. PubMed ID: 26514498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 promoter hypermethylation is associated with increased breast cancer risk.
    Wang L; Tang L; Xie R; Nie W; Chen L; Guan X
    Mol Med Rep; 2012 Oct; 6(4):904-8. PubMed ID: 22824969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
    Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
    Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
    Cao Z; Wei L; Zhu W; Yao X
    Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of hypermethylation of p16 gene in esophageal cancer.
    Xu R; Wang F; Wu L; Wang J; Lu C
    Cancer Biomark; 2013; 13(4):215-26. PubMed ID: 24240582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abberant methylation of p16, HIC1, N33 and GSTP1 genes in tumor epitelium and tumor-associated stromal cells of prostate cancer].
    Kekeeva TV; Popova OP; Shegaĭ PV; Alekseev BIa; Adnreeva IuIu; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2007; 41(1):79-85. PubMed ID: 17380894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the p16 tumor suppressor gene in early-stage prostate cancer.
    Gu K; Mes-Masson AM; Gauthier J; Saad F
    Mol Carcinog; 1998 Mar; 21(3):164-70. PubMed ID: 9537647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
    Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of RASSF1 promoter methylation in prostate cancer.
    Daniunaite K; Jarmalaite S; Kalinauskaite N; Petroska D; Laurinavicius A; Lazutka JR; Jankevicius F
    J Urol; 2014 Dec; 192(6):1849-55. PubMed ID: 24980613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
    Padar A; Sathyanarayana UG; Suzuki M; Maruyama R; Hsieh JT; Frenkel EP; Minna JD; Gazdar AF
    Clin Cancer Res; 2003 Oct; 9(13):4730-4. PubMed ID: 14581343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.